By the end of this BC ECHO on Substance Use session, participants will be able to:
1) compare extended-release buprenorphine to other opioid agonist treatments, including the benefits, side effects, and additional considerations, 
2) discuss induction strategies for extended-release buprenorphine, and 
3) describe strategies to prevent and manage breakthrough withdrawal for people receiving extended-release buprenorphine